Yayun Chi

2.1k total citations
67 papers, 1.5k citations indexed

About

Yayun Chi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yayun Chi has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 34 papers in Cancer Research and 24 papers in Oncology. Recurrent topics in Yayun Chi's work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (14 papers) and RNA Research and Splicing (10 papers). Yayun Chi is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (14 papers) and RNA Research and Splicing (10 papers). Yayun Chi collaborates with scholars based in China, United States and Switzerland. Yayun Chi's co-authors include Jiong Wu, Jingyan Xue, Rong Guo, Sheng Huang, Weiru Chi, Bingqiu Xiu, Shenglin Huang, Ping Wei, Zhao‐Hui Wu and Naisi Huang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yayun Chi

65 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yayun Chi China 23 1.0k 705 348 177 158 67 1.5k
Lin Guo China 21 731 0.7× 440 0.6× 332 1.0× 180 1.0× 78 0.5× 71 1.3k
Mei Dong China 18 1.2k 1.2× 332 0.5× 539 1.5× 159 0.9× 159 1.0× 36 1.7k
Yari Ciani Italy 18 933 0.9× 482 0.7× 394 1.1× 213 1.2× 62 0.4× 27 1.4k
Vasily N. Aushev United States 16 726 0.7× 383 0.5× 397 1.1× 127 0.7× 100 0.6× 59 1.1k
Andrea P. Myers United States 17 788 0.8× 294 0.4× 299 0.9× 202 1.1× 172 1.1× 36 1.3k
Katrin E. Tagscherer Germany 22 897 0.9× 368 0.5× 564 1.6× 227 1.3× 166 1.1× 46 1.5k
Kyong‐Ah Yoon South Korea 23 910 0.9× 593 0.8× 526 1.5× 368 2.1× 185 1.2× 76 1.6k
Jeannine Geneix France 15 962 0.9× 561 0.8× 630 1.8× 126 0.7× 178 1.1× 16 1.6k
Armin Zebisch Austria 19 895 0.9× 302 0.4× 331 1.0× 117 0.7× 221 1.4× 57 1.5k
Sunita Shankar United States 11 1.6k 1.5× 873 1.2× 317 0.9× 268 1.5× 65 0.4× 21 2.0k

Countries citing papers authored by Yayun Chi

Since Specialization
Citations

This map shows the geographic impact of Yayun Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yayun Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yayun Chi more than expected).

Fields of papers citing papers by Yayun Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yayun Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yayun Chi. The network helps show where Yayun Chi may publish in the future.

Co-authorship network of co-authors of Yayun Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Yayun Chi. A scholar is included among the top collaborators of Yayun Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yayun Chi. Yayun Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Lin, Yayun Chi, Ning Liu, et al.. (2025). Targeting neutrophil dysfunction in acute lung injury: Insights from active components of Chinese medicine. Phytomedicine. 141. 156664–156664. 3 indexed citations
2.
Zhang, Qi, Yi Zhang, Li-Yi Zhang, et al.. (2025). LINC01235 Promotes Clonal Evolution through DNA Replication Licensing‐Induced Chromosomal Instability in Breast Cancer. Advanced Science. 12(14). e2413527–e2413527. 1 indexed citations
3.
Chi, Weiru, Bingqiu Xiu, Qi Zhang, et al.. (2025). PPARG Activation of Fatty Acid Metabolism Drives Resistance to Anti-HER2 Therapies in HER2-Positive Breast Cancer. International Journal of Biological Sciences. 21(6). 2396–2414. 3 indexed citations
4.
Chi, Weiru, Yuwei Ma, Qí Zhāng, et al.. (2024). DUSP4 enhances therapeutic sensitivity in HER2-positive breast cancer by inhibiting the G6PD pathway and ROS metabolism by interacting with ALDOB. Translational Oncology. 46. 102016–102016. 3 indexed citations
5.
Zheng, Shuyue, Benlong Yang, Lun Li, et al.. (2024). CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration. International Immunopharmacology. 129. 111625–111625. 4 indexed citations
6.
Chi, Weiru, Bingqiu Xiu, Pei Li, et al.. (2023). MNX1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive Breast Cancer. International Journal of Molecular Sciences. 25(1). 221–221. 2 indexed citations
8.
Song, Aixia, Shibin Hu, Linna Peng, et al.. (2022). Coordinated regulation of RNA polymerase II pausing and elongation progression by PAF1. Science Advances. 8(13). eabm5504–eabm5504. 35 indexed citations
9.
Si, Jing, Rong Guo, Bingqiu Xiu, et al.. (2022). Stabilization of CCDC102B by Loss of RACK1 Through the CMA Pathway Promotes Breast Cancer Metastasis via Activation of the NF-κB Pathway. Frontiers in Oncology. 12. 927358–927358. 8 indexed citations
10.
Li, Pei, Bingqiu Xiu, Li-Yi Zhang, et al.. (2022). The Prognoses of Young Women With Breast Cancer (≤35 years) With Different Surgical Options: A Propensity Score Matching Retrospective Cohort Study. Frontiers in Oncology. 12. 795023–795023. 8 indexed citations
11.
Li, Pei, et al.. (2021). Development and Validation of a Robust Ferroptosis-Related Gene Panel for Breast Cancer Disease-Specific Survival. Frontiers in Cell and Developmental Biology. 9. 709180–709180. 8 indexed citations
13.
Chi, Yayun, Jingyan Xue, Sheng Huang, et al.. (2019). CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50. Theranostics. 9(23). 6840–6855. 42 indexed citations
14.
Guo, Liang, et al.. (2017). Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients. Scientific Reports. 7(1). 44674–44674. 35 indexed citations
15.
Chi, Yayun, Weixiang Chen, Xiaochen Chen, et al.. (2015). Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency.. PubMed Central. 8(11). 20988–1000. 46 indexed citations
16.
Chi, Yayun, Sheng Huang, Mengying Liu, et al.. (2015). Cyclin D3 predicts disease-free survival in breast cancer. Cancer Cell International. 15(1). 89–89. 20 indexed citations
17.
Chi, Yayun, Lisha Wang, Xiuying Xiao, et al.. (2014). Abnormal expression of CDK11p58 in prostate cancer. Cancer Cell International. 14(1). 2–2. 11 indexed citations
18.
Chi, Yayun, Sheng Huang, Lei Wang, et al.. (2014). CDK11p58inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling. BMC Cancer. 14(1). 577–577. 25 indexed citations
19.
20.
Kong, Xiangfei, Yuqing Hao, Chunming Cheng, et al.. (2009). CDK11p58 Phosphorylation of PAK1 Ser174 Promotes DLC2 Binding and Roles on Cell Cycle Progression. The Journal of Biochemistry. 146(3). 417–427. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026